The 6 W’s: Who, what, where, when, why and what of it Read more…
Which RegMed companies are making moves in the 1st hour Read more…
Additional 620,689 shares brings it to $69 M Read more…
Shareholders approve proposals of acquisition of stem cell assets Read more…
Stocks seen down on Fed fears, China Read more…
$60 M in proceeds Read more…
Except we have no fiddler in the RegMed sector playing the music! Read more…
The 6 W’s: Who, what, where, when, why and what of it Read more…
Which RegMed companies are making moves in the 1st hour? Read more…
Publicly Traded Companies Targeting Cancer Stem Cells Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.